Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome-Reference-Cited by-同舟云学术

Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome

Published:2017-10 Issue: Volume:217 Page:18-22
ISSN:0301-2115
Container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology
language:en
Short-container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology

Author:

Tripathy Priyadarshini,Sahu Asutosh,Sahu Mahija,Nagy Attila

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference31 articles.

1. Polycystic ovary syndrome;Nandi;Endocrinol Metab Clin North Am,2014

2. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults;Neeland;Obesity (Silver Spring),2013

3. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction;Bays;Curr Opin Endocrinol Diabetes Obes,2014

4. Ultrasonography for the evaluation of visceral fat and cardiovascular risk;Ribeiro-Filho;Hypertension,2001

5. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography;Hirooka;Intern Med,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abdominal obesity and adipose tissue depots: Focus on intra-abdominal versus subcutaneous adipose tissue depots in Asian Indians;Metabolic Syndrome;2024

2. Polycystic Ovarian Syndrome: a Risk Factor for Cardiovascular Disease;Current Atherosclerosis Reports;2023-12

3. Clinical observation of laparoscopic sleeve gastrectomy and metformin treatment in obese PCOS patients;Journal of Medical Biochemistry;2023-09-13

4. Influence of hsCRP Parameter on the Occurrence of Metabolic Syndrome in Patients with Polycystic Ovary Syndrome;Biomedicines;2023-07-10

5. Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome;Diabetes/Metabolism Research and Reviews;2023-07